These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

79 related articles for article (PubMed ID: 1438105)

  • 1. [Antidiabetic efficacy of benfluorex. Clinical data].
    Brun JM
    Presse Med; 1992 Sep; 21(28):1344-52. PubMed ID: 1438105
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Addition of benfluorex to biguanide improves glycemic control in obese non-insulin-dependent diabetes: a double-blind study versus placebo.
    Roger P; Auclair J; Drain P
    J Diabetes Complications; 1999; 13(2):62-7. PubMed ID: 10432168
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Benfluorex in obese noninsulin dependent diabetes mellitus patients poorly controlled by insulin: a double blind study versus placebo.
    Pontiroli AE; Pacchioni M; Piatti PM; Cassisa C; Camisasca R; Pozza G
    J Clin Endocrinol Metab; 1996 Oct; 81(10):3727-32. PubMed ID: 8855830
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Added benfluorex in obese insulin-requiring type 2 diabetes.
    Leutenegger M; Bauduceau B; Brun JM; Guillon-Metz F; Martin C; Nicolino-Peltier C; Richard JL; Vannereau D
    Diabetes Metab; 1998 Feb; 24(1):55-61. PubMed ID: 9534010
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Benfluorex and blood glucose control in non insulin-dependent diabetic patients.
    Cavallo-Perin P; Estivi P; Boine L; Galletti R; Pacini G; Cobelli C; Pagano G
    J Endocrinol Invest; 1991 Feb; 14(2):109-13. PubMed ID: 2061566
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of insulin reduction with benfluorex on serum dehydroepiandrosterone (DHEA), DHEA sulfate, and blood pressure in hypertensive middle-aged and elderly men.
    Nestler JE; Beer NA; Jakubowicz DJ; Colombo C; Beer RM
    J Clin Endocrinol Metab; 1995 Feb; 80(2):700-6. PubMed ID: 7852539
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Therapeutic effect of benfluorex in type II diabetic patients on diet regimen alone.
    Velussi M; Monte AD; Cernigoi AM
    J Diabetes Complications; 1996; 10(5):261-6. PubMed ID: 8887014
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Mechanisms of hypoglycemic action of benfluorex].
    Vigili de Kreutzenberg S; Riccio A; Dorella M; Da Tos V; Del Prato S
    Presse Med; 1992 Sep; 21(28):1340-3. PubMed ID: 1438104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Mode of action of benfluorex. Recent data].
    Brindley DN
    Presse Med; 1992 Sep; 21(28):1330-5. PubMed ID: 1438102
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Benfluorex action on metabolic control and insulin sensitivity in type 2 non-insulin dependent diabetics.
    Pasquali R; Colella P; Capelli M; Zannarini L; Melchionda N; Barbara L
    Panminerva Med; 1989; 31(3):114-8. PubMed ID: 2689969
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic benefit of benfluorex in type II diabetic patients treated with sulfonylureas.
    Stucci N; de Gregoris P; Lavielle R; Tomasi F
    J Diabetes Complications; 1996; 10(5):267-73. PubMed ID: 8887015
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanism of metformin action in obese and lean noninsulin-dependent diabetic subjects.
    DeFronzo RA; Barzilai N; Simonson DC
    J Clin Endocrinol Metab; 1991 Dec; 73(6):1294-301. PubMed ID: 1955512
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of benfluorex on insulin secretion and insulin action in streptozotocin-diabetic rats.
    Portha B; Serradas P; Bailbé D; Blondel O; Picarel F
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():57S-63S. PubMed ID: 8299491
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Benfluorex normalizes hyperglycemia and reverses hepatic insulin resistance in STZ-induced diabetic rats.
    Serradas P; Blondel O; Bailbe D; Portha B
    Diabetes; 1993 Apr; 42(4):564-70. PubMed ID: 8454107
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Moxonidine improves glycaemic control in mildly hypertensive, overweight patients: a comparison with metformin.
    Chazova I; Almazov VA; Shlyakhto E
    Diabetes Obes Metab; 2006 Jul; 8(4):456-65. PubMed ID: 16776753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiatherogenic effects of long-term benfluorex treatment in male insulin resistant JCR:LA-cp rats.
    Russell JC; Graham SE; Dolphin PJ; Amy RM; Wood GO; Brindley DN
    Atherosclerosis; 1997 Jul; 132(2):187-97. PubMed ID: 9242964
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of metformin versus the prandial insulin secretagogue, repaglinide, on fasting and postprandial glucose and lipid responses in non-obese patients with type 2 diabetes.
    Lund SS; Tarnow L; Frandsen M; Smidt UM; Pedersen O; Parving HH; Vaag AA
    Eur J Endocrinol; 2008 Jan; 158(1):35-46. PubMed ID: 18166815
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anti-hyperglycaemic mechanisms of benfluorex in type II diabetes mellitus.
    De Feo P; Lavielle R; De Gregoris P; Bolli GB
    Diabetes Metab Rev; 1993 Nov; 9 Suppl 1():35S-41S. PubMed ID: 8299487
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparative three-month study of the efficacies of metformin and gliclazide in the treatment of NIDD.
    Noury J; Nandeuil A
    Diabete Metab; 1991 May; 17(1 Pt 2):209-12. PubMed ID: 1936478
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of benfluorex in obese patients with metabolic disorders.
    di Martino G; Federico P; Mattera E; Jacono G
    Br J Clin Pract; 1989 Jun; 43(6):201-8. PubMed ID: 2597599
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.